2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
87
Leukemia
49
Lymphoma
21
Burkitt Lymphoma
19
Leukemia, Biphenotypic, Acute
14
Leukemia, Myeloid, Acute
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma, Extranodal NK-T-Cell
8
Recurrence
6
Lymphoma, Non-Hodgkin
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Myelodysplastic Syndromes
4
Dendritic Cell Sarcoma, Interdigitating
4
Neoplasm, Residual
3
Down Syndrome
3
Anemia, Refractory, with Excess of Blasts
3
Myeloproliferative Disorders
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Monocytic, Acute
2
Leukemia, Erythroblastic, Acute
2
Leukemia, Eosinophilic, Acute
2
Anemia, Refractory
2
Thrombocytopenia
1
Sarcoma, Myeloid
1
Pancreatic Neoplasms
1
Neutropenia
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Interventions
Doxorubicin
17
Echocardiography
14
Exercise
9
Cyclophosphamide
9
Trastuzumab
8
Dexrazoxane
8
Electrocardiography
7
Razoxane
6
Carvedilol
6
Vincristine
4
Radiotherapy
4
Filgrastim
4
Docetaxel
4
Methotrexate
3
Granulocyte Colony-Stimulating Factor
3
Etoposide
3
Cisplatin
3
Atorvastatin
3
salicylhydroxamic acid
2
sacubitril and valsartan sodium hydrate drug combination
2
empagliflozin
2
dapagliflozin
2
Tablets
2
Social Determinants of Health
2
Silymarin
2
Prednisone
2
Paclitaxel
2
Neoadjuvant Therapy
2
Magnetic Resonance Spectroscopy
2
Leucovorin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Asparaginase
×
Clear all
NCT01230983
2013-06-06
T-Cell #4
Children's Oncology Group
Phase 3
Completed
573 enrolled